本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

39.63
+1.012.60%
成交量:145.94万
成交额:5,764.56万
市值:75.24亿
市盈率:-11.21
高:39.85
开:39.46
低:38.69
收:38.62
数据加载中...
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities